Home

Malawi Tether Laboratorium reuters teva Tjene null tennis

TEVA.TA - | Stock Price & Latest News | Reuters
TEVA.TA - | Stock Price & Latest News | Reuters

Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters

Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN  Business
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business

Teva may pay as much as $3.6 billion in opioid settlement | Business  Insurance
Teva may pay as much as $3.6 billion in opioid settlement | Business Insurance

Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters

Teva Pharmaceuticals Slashing 25% of Workforce, Suspending Dividend
Teva Pharmaceuticals Slashing 25% of Workforce, Suspending Dividend

Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters

A Teva Pharmaceutical Industries building is seen in Jerusalem December 14,  2017. REUTERS/Ammar Awad Stock Photo - Alamy
A Teva Pharmaceutical Industries building is seen in Jerusalem December 14, 2017. REUTERS/Ammar Awad Stock Photo - Alamy

Netanyahu Asks Teva Pharm to Minimize Job Loss in Israel
Netanyahu Asks Teva Pharm to Minimize Job Loss in Israel

Teva Pharm Sees Close of $40.5 Billion Allergan Generics Deal by June
Teva Pharm Sees Close of $40.5 Billion Allergan Generics Deal by June

Teva reaches proposed settlement of opioid lawsuits | Business Insurance
Teva reaches proposed settlement of opioid lawsuits | Business Insurance

Teva to pay up to $4.2 billion in U.S. to settle opioid claims | Reuters
Teva to pay up to $4.2 billion in U.S. to settle opioid claims | Reuters

Teva Pharm Expects About 25 Percent of EpiPen Market by Year End
Teva Pharm Expects About 25 Percent of EpiPen Market by Year End

Teva could pay $3.6b to settle opioid dispute - report - Globes
Teva could pay $3.6b to settle opioid dispute - report - Globes

Teva, AbbVie finalize $6.6 billion U.S. opioid settlements | Reuters
Teva, AbbVie finalize $6.6 billion U.S. opioid settlements | Reuters

Teva settles shareholder lawsuit over generic drug | Business Insurance
Teva settles shareholder lawsuit over generic drug | Business Insurance

TEVA.N) | Stock Price & Latest News | Reuters
TEVA.N) | Stock Price & Latest News | Reuters

Teva Pharm expects U.S. opioid case settlements to cost $2.6 bln | Reuters
Teva Pharm expects U.S. opioid case settlements to cost $2.6 bln | Reuters

Opioid Maker Teva Proposes $4.35 Billion in Nationwide Settlement -  Business - Haaretz.com
Opioid Maker Teva Proposes $4.35 Billion in Nationwide Settlement - Business - Haaretz.com

Teva, Texas strike opioid settlement worth $225M | Business Insurance
Teva, Texas strike opioid settlement worth $225M | Business Insurance

Teva lied about opioid role, New York says | Reuters
Teva lied about opioid role, New York says | Reuters

Walgreens, Teva accused of fueling opioid addiction in quest for new  markets | Reuters
Walgreens, Teva accused of fueling opioid addiction in quest for new markets | Reuters

Averting opioid trial, Teva, drug distributors reach last-gasp settlement -  The Jerusalem Post
Averting opioid trial, Teva, drug distributors reach last-gasp settlement - The Jerusalem Post

Teva Names Interim CEO, New Chairman As Vigodman Steps Down
Teva Names Interim CEO, New Chairman As Vigodman Steps Down

Teva to buy U.S. drug developer Auspex Pharma for $3.5 billion | Reuters.com
Teva to buy U.S. drug developer Auspex Pharma for $3.5 billion | Reuters.com

Teva taps new CFO, hikes legal set-aside to more than $1B as opioid deal  falters | Fierce Pharma
Teva taps new CFO, hikes legal set-aside to more than $1B as opioid deal falters | Fierce Pharma

Teva Pharma to sell more women's health assets for $1.38 billion | Reuters
Teva Pharma to sell more women's health assets for $1.38 billion | Reuters

Teva To Start Nationwide Settlement Of Opioid Lawsuits From Next Year:  Report
Teva To Start Nationwide Settlement Of Opioid Lawsuits From Next Year: Report

Teva faces class-action lawsuit over US antitrust probe into price-fixing |  The Times of Israel
Teva faces class-action lawsuit over US antitrust probe into price-fixing | The Times of Israel